Free Trial

1492 Capital Management LLC Boosts Holdings in MaxLinear, Inc (NASDAQ:MXL)

MaxLinear logo with Computer and Technology background

1492 Capital Management LLC raised its holdings in shares of MaxLinear, Inc (NASDAQ:MXL - Free Report) by 34.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 199,286 shares of the semiconductor company's stock after purchasing an additional 50,799 shares during the quarter. 1492 Capital Management LLC owned 0.24% of MaxLinear worth $2,164,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Victory Capital Management Inc. grew its stake in shares of MaxLinear by 30.9% in the 1st quarter. Victory Capital Management Inc. now owns 1,067,728 shares of the semiconductor company's stock worth $11,596,000 after acquiring an additional 251,797 shares in the last quarter. Larson Financial Group LLC grew its stake in shares of MaxLinear by 144.3% in the 1st quarter. Larson Financial Group LLC now owns 6,863 shares of the semiconductor company's stock worth $75,000 after acquiring an additional 4,054 shares in the last quarter. Edgestream Partners L.P. bought a new stake in shares of MaxLinear in the 1st quarter worth $1,870,000. CWM LLC grew its position in MaxLinear by 119.6% during the first quarter. CWM LLC now owns 10,050 shares of the semiconductor company's stock valued at $109,000 after buying an additional 5,474 shares during the period. Finally, Principal Financial Group Inc. grew its position in MaxLinear by 2.7% during the first quarter. Principal Financial Group Inc. now owns 384,677 shares of the semiconductor company's stock valued at $4,178,000 after buying an additional 9,955 shares during the period. Institutional investors own 90.79% of the company's stock.

MaxLinear Trading Down 5.2%

Shares of MaxLinear stock traded down $0.89 on Friday, hitting $16.36. The stock had a trading volume of 2,783,894 shares, compared to its average volume of 1,549,865. The company has a quick ratio of 1.19, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. MaxLinear, Inc has a one year low of $8.35 and a one year high of $25.73. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of -6.62 and a beta of 1.72. The stock's 50-day simple moving average is $13.49 and its two-hundred day simple moving average is $14.09.

MaxLinear (NASDAQ:MXL - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The semiconductor company reported $0.02 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.02. MaxLinear had a negative net margin of 55.53% and a negative return on equity of 18.16%. The firm had revenue of $108.81 million for the quarter, compared to analysts' expectations of $104.94 million. During the same quarter last year, the business earned ($0.25) earnings per share. The business's revenue was up 18.3% on a year-over-year basis. As a group, sell-side analysts predict that MaxLinear, Inc will post -0.37 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Wells Fargo & Company increased their target price on shares of MaxLinear from $13.00 to $18.00 and gave the stock an "equal weight" rating in a research report on Thursday. Stifel Nicolaus raised their target price on shares of MaxLinear from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Friday, July 18th. Benchmark raised their target price on shares of MaxLinear from $20.00 to $25.00 and gave the company a "buy" rating in a research note on Thursday. Wall Street Zen raised shares of MaxLinear from a "hold" rating to a "buy" rating in a research note on Saturday. Finally, Loop Capital lowered their target price on shares of MaxLinear from $18.00 to $10.00 and set a "hold" rating on the stock in a research note on Tuesday, April 29th. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $18.69.

Get Our Latest Report on MXL

Insider Activity

In related news, Director Ted L. Tewksbury III sold 6,071 shares of MaxLinear stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $10.40, for a total value of $63,138.40. Following the sale, the director owned 74,995 shares in the company, valued at $779,948. The trade was a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 7.80% of the company's stock.

MaxLinear Company Profile

(Free Report)

MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.

Featured Articles

Institutional Ownership by Quarter for MaxLinear (NASDAQ:MXL)

Should You Invest $1,000 in MaxLinear Right Now?

Before you consider MaxLinear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.

While MaxLinear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines